In one paragraphArticle in The Journal of cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Ryan L HuizarDepartment of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-4695-9674 James V McCannDepartment of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0009-0006-3868-4438 Malak AmerDepartment of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-0590-3156 Beza WoldemeskelDepartment of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-4988-4989 Daisuke MurataDepartment of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-3829-6620 Nanami SenooDepartment of Physiology, Pharmacology and Therapeutics, Mitochondrial Phospholipid Research Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-5260-3848 Abhijit Deb RoyCenter for Cell Analysis and Modeling and Department of Cell Biology, University of Connecticut School of Medicine, Farmington, CT, USA.ORCID 0000-0003-1640-2402 Benjamin C OrsburnOrgan Pathobiology and Therapeutics Institute, The University of Pittsburgh , Pittsburgh, PA, USA.ORCID 0000-0002-0774-3750 Steven M ClaypoolDepartment of Physiology, Pharmacology and Therapeutics, Mitochondrial Phospholipid Research Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-5316-1623 Hiromi SesakiDepartment of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-6877-3929 Miho IijimaDepartment of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-3073-9135 Namandjé N BumpusOrgan Pathobiology and Therapeutics Institute, The University of Pittsburgh , Pittsburgh, PA, USA.ORCID 0000-0002-6096-3824 Takanari InoueDepartment of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-7957-7624 Andrew J EwaldDepartment of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-1964-0740 Funding
Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI Rosalie Wollett · 1985 to 2026
$208.6MMedical Scientist Training ProgramT32GM136577 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ANDREA L COX · 2020 to 2026
$13.4MTech Core 2U54CA268083 · NCI · JOHNS HOPKINS UNIVERSITY · PI Denis Wirtz · 2022 to 2026
$10.2MCellular Signaling in Drug Induced ToxicityR01GM103853 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ORSBURN, BENJAMIN CARL · 2013 to 2022
$3.6MDecoding dynamic interplay between signaling and membranes in chemotaxis bymolecular actuatorsR35GM149329 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Takanari Inoue · 2023 to 2026
$2.8MMapping the single cell state basis of metastasis in space and timeU01CA284090 · NCI · JOHNS HOPKINS UNIVERSITY · PI Andrew Josef Ewald · 2023 to 2026
$2.7MAn intimate and multifaceted partnership: cardiolipin and the mitochondrial ADP/ATP carrierR01HL165729 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Steven Michael Claypool · 2023 to 2026
$2.1MEndoplasmic reticulum-assisted mitochondrial precursor biogenesis and quality controlR01GM151746 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Steven Michael Claypool · 2023 to 2026
$1.3MMolecular basis to regulate the cardiac-specific form of mitochondrial phospholipid cardiolipinK99HL168075 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SENOO, NANAMI · 2024 to 2025
$215kAmerican Heart Association 23POST1057352Barth Syndrome Foundation 828058Breast Cancer Research Foundation BCRF-25-048Hope Scarves FoundationJayne Koskinas Ted Giovanis FoundationNIH HHS K99HL168075NIH HHS P30CA006973NIH HHS R01GM103853NIH HHS R01GM151746NIH HHS R01HL165729NIH HHS R35GM149329NIH HHS T32GM136577NIH HHS U01CA284090NIH HHS U54CA268083
6 · The paper itselfAbstract
E-cadherin suppresses invasion and promotes metastasis in invasive ductal breast cancer, through suppression of reactive oxygen species (ROS). We sought to determine the cellular source of apoptosis-inducing ROS and to identify the domains of E-cadherin that are essential for cancer cell survival. Inhibition of mitochondria-derived ROS was sufficient to rescue cell death following E-cadherin deletion, in both 3D colony formation and in vivo metastasis assays. We next generated Cdh1 constructs by mutating amino acids or deleting domains, then tested their ability to rescue colony formation in E-cadherin-deleted cells. Surprisingly, E-cadherin constructs in which the extracellular domains were deleted, adhesion was compromised, or catenin interactions were blocked could rescue elevated mitochondrial ROS and 3D colony formation. Conversely, a construct lacking the cytoplasmic domain was unable to rescue ROS or cell death. Our findings reveal that E-cadherin's ability to regulate mitochondrial ROS, cancer cell survival, and metastatic outgrowth is separable from its role in intercellular adhesion.
Indexed as
Breast NeoplasmsCadherinsAnimalsAntigens, CDApoptosisCell AdhesionCell Line, TumorCell SurvivalFemaleHumansMiceMitochondriaNeoplasm InvasivenessNeoplasm MetastasisReactive Oxygen SpeciesAntigens, CDCadherinsReactive Oxygen Species
Identifiers
PMID42911134
PMCPMC13689684
What OpenQuestion holds
Textmetadata
Read underepoch 390